Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 7.15B | 7.44B | 6.47B | 6.17B | 5.73B | 4.90B |
Gross Profit | 3.44B | 3.59B | 3.05B | 2.89B | 2.56B | 2.16B |
EBITDA | 1.50B | 2.01B | 1.38B | 1.64B | 1.31B | 1.01B |
Net Income | 760.35M | 961.66M | 518.82M | 725.15M | 530.27M | 408.88M |
Balance Sheet | ||||||
Total Assets | 9.31B | 9.61B | 8.42B | 7.87B | 7.22B | 5.85B |
Cash, Cash Equivalents and Short-Term Investments | 5.70B | 5.56B | 4.89B | 4.37B | 3.58B | 1.96B |
Total Debt | 67.00M | 65.16M | 73.39M | 86.46M | 104.19M | 121.56M |
Total Liabilities | 2.69B | 3.04B | 2.38B | 2.24B | 2.35B | 2.00B |
Stockholders Equity | 6.62B | 6.57B | 6.03B | 5.63B | 4.87B | 3.85B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.73B | 650.31M | 773.45M | 1.12B | 118.58M |
Operating Cash Flow | 0.00 | 1.99B | 1.22B | 1.21B | 1.60B | 1.12B |
Investing Cash Flow | 0.00 | -870.84M | -571.46M | -434.42M | -477.89M | -1.07B |
Financing Cash Flow | 0.00 | -429.58M | -126.47M | 6.33M | 486.31M | -17.49M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥26.34B | 12.88 | 5.10% | 13.49% | 24.79% | ||
77 Outperform | ¥26.21B | 10.89 | 1.19% | 11.94% | 14.10% | ||
76 Outperform | ¥20.73B | 21.22 | 0.69% | 15.09% | 85.53% | ||
73 Outperform | ¥27.95B | 22.87 | 0.63% | 10.35% | 98.15% | ||
69 Neutral | ¥228.59B | 14.33 | 7.64% | 2.71% | 9.13% | 8.49% | |
65 Neutral | ¥23.15B | 32.02 | 1.81% | 7.60% | -6.99% | ||
59 Neutral | ¥10.59B | ― | ― | 8.68% | 13.81% |